MCMCB Pro
J1736

J1736Injection, meloxicam (delova), 1 mg

HCPCSActiveBETOS O1E

J1736 is a HCPCS Level II code for injection, meloxicam (delova), 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for J1736

Long descriptor
Injection, meloxicam (delova), 1 mg

The official wording. This is what the code means.

Short descriptor
Inj meloxicam (delova) 1mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2026

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J1736

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1736 is not quite right, the correct code is very often within a few positions of it.

  • J1675Injection, histrelin acetate, 10 micrograms
  • J1700Injection, hydrocortisone acetate, up to 25 mg
  • J1710Injection, hydrocortisone sodium phosphate, up to 50 mgterminated
  • J1720Injection, hydrocortisone sodium succinate, up to 100 mg
  • J1725Injection, hydroxyprogesterone caproate, 1 mgterminated
  • J1726Injection, hydroxyprogesterone caproate, (makena), 10 mg
  • J1729Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
  • J1730Injection, diazoxide, up to 300 mg
  • J1737Injection, meloxicam (azurity), 1 mg
  • J1738Injection, meloxicam, 1 mg
  • J1740Injection, ibandronate sodium, 1 mg
  • J1741Injection, ibuprofen, 100 mg
  • J1742Injection, ibutilide fumarate, 1 mg
  • J1743Injection, idursulfase, 1 mg
  • J1744Injection, icatibant, 1 mg
  • J1745Injection, infliximab, excludes biosimilar, 10 mg

Questions about J1736

What is HCPCS code J1736?

J1736 is a HCPCS Level II code for injection, meloxicam (delova), 1 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J1736?

The CMS HCPCS file marks J1736 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is J1736 paid under the physician fee schedule?

J1736 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026